Mr kia
It's pretty simple. The only thing that will positively affect the SP is a deal or some positive news.
There are 2 things that I am looking for before the end of the 2nd quarter. Some one paying for the second Phase 3 clinical trials for ArTiMist prereferral purposes and the FDA class 3 meeting results indicating a path to NDA of SUD01. Either of these may pop the SP.
Otherwise wait till it falls below the last CR level of 3.6c then buy.
Otherwise I'm holding.
MMV Pre-referral treatment, severe malaria, page-31
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.015(11.1%) |
Mkt cap ! $157.7M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 15.0¢ | 14.0¢ | $106.6K | 736.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 487932 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.36pm 16/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |